A mitochondria-mediated apoptotic pathway induced by deoxynivalenol in human colon cancer cells.

Yanna Ma,Aihua Zhang,Zhiyu Shi,Chenghua He,Jujing Ding,Xichun Wang,Jifei Ma,Haibin Zhang
DOI: https://doi.org/10.1016/j.tiv.2012.01.010
IF: 3.685
2012-01-01
Toxicology in Vitro
Abstract:Deoxynivalenol (DON), known colloquially as "vomitoxin", is a pathogenic mycotoxin produced by Fusarium fungi. Human food poisoning outbreaks, with nausea, diarrhea, and vomiting as primary symptoms, have been associated with Fusarium-infected cereals. Therefore, this study was designed to determine the molecular aspects of DON in human colon cancer cells (HT-29). To this aim, we have monitored the effects of DON on (i) cellular morphological changes via optical and transmission electron microscopy, especially in regards to cell viability and mitochondria changes, and (ii) its effects on key regulators of cell apoptosis, including cytochrome c, caspase-9, caspase-3, Bcl-2, Box, and Bid. Our results showed that DON treatment inhibited cell proliferation, induced significant morphological changes, and promoted the activation of cytochrome c and caspases. Furthermore, changes in Bcl-2, Box, and Bid expression were detected. The relative expression profile of Bcl-2 was contrary to that of Box and Bid, as Bcl-2 expression decreased as the concentrations DON increased, reaching a minimum at the highest concentration of DON. We concluded that DON-induced apoptosis was caused by mitochondrial dysfunction and subsequent release of cytochrome c into the cytoplasm and successive activation of caspases, and this was likely regulated by Bcl-2 family proteins. (C) 2012 Elsevier Ltd. All rights reserved.
What problem does this paper attempt to address?